Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Novel Predictors of ART Outcomes
Authors not listed
University of Oklahoma · 2009
Abstract
The goals of this research proposal are to further our understanding of the reproductive aging process in women and to improve our ability to clinically assess and model reproductive aging. Reproductive aging is a continuous process that begins many years prior to menopause. Women in their late 30s and early 40s usually maintain normal menstrual function and ovulatory status, yet fertility in these women is considerably compromised compared to younger women. The primary mechanism of reproductive aging is through the process of ovarian primordial follicle (egg) depletion, a process that exhibits considerable variation between women. As a result, the age at which an individual begins to experience infertility and menstrual cycle changes secondary to follicle depletion also varies significantly and is difficult to predict. The clinical assessment of the number of primordial follicles remaining in the ovary has traditionally relied upon the measurement of ovarian or pituitary hormones such as FSH, estradiol, and inhibin B. Unfortunately, these measures are all indirect and poorly sensitive in the assessment of ovarian reserve. More recently, serum levels of anti-Müllerian hormone (AMH) and the ovarian antral follicle count have been utilized as clinical measures of ovarian reserve. Both have been correlated with chronological age and have some predictive power in determining stimulation quantity (the number of oocytes obtained at the time of egg-recovery) in in-vitro fertilization (IVF) treatment cycles. Reproductive aging in women; however, is more than just the depletion of oocytes from a woman's ovaries, but also involves a decline in oocyte quality. The predictive value of these clinical markers of ovarian reserve with regards to oocyte quality is unknown. Additionally, new tools developed to assess biological aging in other organ systems such as white blood cell telomere(definition) length and the measurement of advanced glycation end products (AGEs) through skin autofluorescence have not been evaluated with respect to the reproductive aging process. This proposal seeks to develop better models of normal female reproductive aging by identifying novel markers of ovarian reserve and determining their relationship with both oocyte quantity and quality obtained during IVF treatment cycles.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Anonymous. (2009). Novel Predictors of ART Outcomes. <em>University of Oklahoma</em>. https://clinicaltrials.gov/study/NCT00988611
Vancouver
Anonymous. Novel Predictors of ART Outcomes. University of Oklahoma. 2009.
BibTeX
@misc{anon2009NovelP,
title = {Novel Predictors of ART Outcomes},
author = {Anonymous},
journal = {University of Oklahoma},
year = {2009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Reproductive Medicine and Biology 2026
Open access · CC-BY
The Possibility and Characteristics of Senescence‐Related Changes in Reproductive Tissues Such as the Ovary, Oviduct, and Uterus
Journal of Ovarian Research 2024
Open access · CC-BY
Ovarian aging: energy metabolism of oocytes
Human Reproduction 2025
Open access · OA
O-200 Epigenetic age and fertility timeline: testing an epigenetic clock to forecast in vitro fertilization success rate
Neurobiology of Aging 2024
Open access · OA
A blood biomarker of the pace of aging is associated with brain structure: replication across three cohorts
Human Reproduction 2026
Citation only
L26/P-624 When biological age matters: epigenetic clocks and IVF outcomes
BMC Genomics 2024
Open access · CC-BY